Real-time enrollment status for this metastatic prostate cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 10:55 PM UTC
| NCT Number | NCT05691465 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Prostate Cancer |
| Phase | PHASE2 |
| Target Enrollment | 35 participants |
| Active Locations | 13 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 14, 2026 (Jul 14, 2026) |
As of August 31, 2026: Clinical trial NCT05691465 is currently recruiting participants. This phase2 study for metastatic prostate cancer is actively seeking new participants at 13 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05691465 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05691465 was last updated Jul 14, 2026 (July 14, 2026). HelloStudys verifies this status automatically.